Organogenesis Holdings Inc. (ORGO) Financials

ORGO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 520.0 million 138.6 million
Dec. 31, 2025 598.7 million 164.8 million
Sept. 30, 2025 509.8 million 123.8 million
June 30, 2025 461.1 million 99.9 million

ORGO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 18.0 million 3.6 million
Dec. 31, 2025 34.8 million 4.3 million
Sept. 30, 2025 844000 3.1 million
June 30, 2025 -36.5 million 2.5 million

ORGO Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -53.2 million
Dec. 31, 2025 43.7 million
Sept. 30, 2025 21.6 million
June 30, 2025 -9.4 million

ORGO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 92.1 million - 61.1 million
Dec. 31, 2025 93.7 million 50.7 million 63.5 million
Sept. 30, 2025 64.4 million - 31.0 million
June 30, 2025 73.1 million - 40.8 million

ORGO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 127.8 million
Dec. 31, 2025 132.2 million
Sept. 30, 2025 130.8 million
June 30, 2025 126.9 million

ORGO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3.1 million 15.2 million 65.2 million -
Dec. 31, 2025 4.7 million 10.3 million 100.2 million -
Sept. 30, 2025 2.2 million 13.2 million 79.7 million -
June 30, 2025 3.6 million 10.4 million 73.8 million -

ORGO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 37.2 million 38.1 million
Dec. 31, 2025 225.1 million 49.9 million
Sept. 30, 2025 150.5 million 36.3 million
June 30, 2025 100.8 million 27.6 million

ORGO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ORGO

Price: $2.46

52 week price:
2.04
7.08

Payout Ratio Range:
-519.10%
38.71%

Earnings Per Share: -0.12 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 317113

Market Capitalization: 288.2 million

Links: